Cargando…
High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients
BACKGROUND: Vulvar squamous cell carcinoma is a cancer form with increasing incidence rate and few treatment options. Wee1 is a central regulator of the G2/M DNA-damage checkpoint, and has in previous studies been described as a prognostic biomarker and a potential target for therapy in other cancer...
Autores principales: | Magnussen, Gry Irene, Hellesylt, Ellen, Nesland, Jahn M, Trope, Claes G, Flørenes, Vivi Ann, Holm, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751528/ https://www.ncbi.nlm.nih.gov/pubmed/23767999 http://dx.doi.org/10.1186/1471-2407-13-288 |
Ejemplares similares
-
Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
por: Wang, Zhihui, et al.
Publicado: (2010) -
High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy
por: Magnussen, Gry Irene, et al.
Publicado: (2012) -
The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas
por: Wang, Zhihui, et al.
Publicado: (2008) -
Primary Tumor Vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact
por: Dhakal, Hari Prasad, et al.
Publicado: (2013) -
Expression of p15(INK4b) and p57(KIP2) and Relationship with Clinicopathological Features and Prognosis in Patients with Vulvar Squamous Cell Carcinoma
por: Holm, Ruth, et al.
Publicado: (2013)